Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Keratin 8 pseudogene 18 (KRT8P18) is classified as a pseudogene related by sequence to the keratin 8 gene. It does not code for a functional protein and has no known biological function, disease associations, or role as a drug target. Its existence is primarily noted in genomic studies and gene annotation resources as a non-functional DNA sequence sharing homology with the protein-coding keratin genes.[4] KRT8P18 is not a receptor, enzyme, transporter, or target in therapeutic development. It is often listed in gene databases, but no protein or functional role is associated with it[4]. Its parent gene, keratin 8 (KRT8), has critical roles in cytoskeletal integrity in epithelial cells, liver disease, and can be a biomarker in pathology, but this does not apply to KRT8P18[5][7]. Pseudogenes like KRT8P18 are generally not involved in cellular function or disease except in rare cases where they may act as regulatory RNAs, and there is no such evidence for KRT8P18. In summary, Keratin 8 pseudogene 18 (KRT8P18) is not a therapeutic target, has no known biological or disease relevance, and is best classified as a non-functional pseudogene[4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Keratin 8 pseudogene 18 (KRT8P18).